ArticleFrontiers in pediatrics2022
Use of blinatumomab and CAR T-cell therapy in children with relapsed/refractory leukemia: A case series study.
Songmi Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it